SciELO - Scientific Electronic Library Online

 
vol.11 número1Biogenesis and mechanism of action of MicroRNAs as serum biomarkers in cardiovascular diseases índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de salud publica del Paraguay

versão impressa ISSN 2224-6193versão On-line ISSN 2307-3349

Resumo

MONTIEL-JAROLIN, Dora Elizabeth et al. Guillain Barré syndrome associated with SARS-CoV-2 infection in a patient with a differential diagnosis of dengue. Rev. salud publica Parag. [online]. 2021, vol.11, n.1, pp.112-116. ISSN 2307-3349.  https://doi.org/10.18004/rspp.2021.junio.112.

Introduction:

Guillain-Barré syndrome has been associated with infection by the SARS-CoV-2 virus since the beginning of the pandemic.

Clinical case:

56-year-old man without comorbidity or toxic habits, consultation for a 4-day history of paresthesia in the hands and feet simultaneously, lower limb weakness, without other symptoms. The patient 22 days before, presented cough and dyspnea, 3 days of evolution, the nasopharyngeal swab for SARS-CoV-2 was positive, with outpatient treatment. He was referred to dengue in december 2019. Physical examination: Blood pressure 140/80 mmHg, heart rate 114 per minute, temperature 36 degrees, respiratory rate 20 per minute. Neurological examination: lucid patient, decreased muscular strength of the lower limbs 4/5, absent osteotendinous reflexes in four limbs, without sensory level or sphincter involvement, negative Babinski sign, absent meningeal signs. Rest of the physical examination without valuable data. Laboratory tests: white blood cells 11.5 x 10 9 / L, neutrophils: 74%, lymphocytes: 18%. Erythrosedimentation 14 mm, glycemia 99 mg / dL urea: 19 mg / dl, creatinine: 0.7 mg / dL, arterial gas: pH: 7.39, pco2: 27, pO2: 76, EB: - 7.6, HCO3 16 SO2: 96 , D-dimer 489 ng / ml. Elisa serology: HIV: negative, IGM serology negative: herpes simplex, cytomegalovirus, dengue antigen NS1: negative; dengue IgG and IgM serology: positive (November 2020, immunochromatographic test, SD, Korea), (SARS-CoV-2 IgG / IgM positive, Zika and chikungunya negative). Antinuclear antibody (ANA): 1/80, anti deoxyribonuclease (anti DNA): negative, serology negative (anti proteinase 3 / myeloperoxidase, extractable antigen from the nucleus) Cerebrospinal fluid: (CSF): (glycorrhachia) : 63 mg / dL protein: 88 mg / dL leukocytes: 2 cells / μl). PCR in CSF for SARS-CoV-2 virus was not performed. Electromyography: Findings suggestive of demyelinating polyradiculoneuropathy. Chest CT scan: pattern in bilateral patched ground glass He was treated with intravenous immunoglobulin with complete recovery of muscle strength.

Discussion:

GBS appeared on day 22 of the COVID-19 disease, there is a temporal relationship, it responds to post-infectious model and the pathogenesis would be autoimmune in nature

Palavras-chave : COVID-19; Guillain-Barré syndrome; SARS-CoV-2; dengue.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )